Search Results For ''

  • Dosing commenced in Phase 2 trial for Pharmaxis’ lead asset myelofibrosis drug

    With a share price that has effectively doubled over the past few months and a drug pipeline beginning to snowball its successes, investors that identified Pharmaxis (ASX: PXS) early on are justifiably ecstatic. The clinical stage drug developers have had a strong start to FY22 with their lead asset, oncology drug PXS-5505 and anti-skin scarring

    Read More
    Public
  • Rising death rates Propel demand for funeral services

    Despite the awkwardness of a pandemic with death being talked about more than ever, Propel Funeral Partners (ASX: PFP) have been diligently handling the sensitivity of increasing death rates which has resulted in greater demand for funeral services. For the Quarter ended 30 September 2021, Propel has reported a 13% increase in revenue compared to

    Read More
    Public
  • Hidden gems: the profitable small caps forging export markets

    As with so many facets of human nature, it’s natural for investors to covet the next big thing wrapped in glittering paper. It’s why tech stocks have done so well in recent years, as well as anything related to battery metals or the buy-now-pay-later sector. It’s also why home-grown hero Canva is valued at a

    Read More
    Public
  • Goodbye lounge room gym! Viva Leisure expands portfolio just in time for lockdown lift

    If you’re like me you’re probably a bit over using your lounge room as an office, cinema, dining room and gym. The multidisciplinary heart of my home is often littered with dumbbells, yoga mats, wine glasses and whatever book I’m currently reading. It’s an odd picture.  The thought of getting back into a real gym,

    Read More
    Public
  • Classified: XTEK receives $1.5m order for ballistic armour from US Government

    An undisclosed US Federal Government department is set to beef up its protection with the order of $1.5 million worth of specialist ballistic armour products from defence manufacturer XTEK (ASX: XTE).  The $1.5m order (USD $1.1m) was placed with XTEK’s wholly-owned subsidiary HighCom Armor Solutions which specialises in advanced ballistic body armour.  “By leveraging advanced

    Read More
    Public
  • Major bank backs neolender Wisr with new $225m vehicle loan warehouse

    If you can’t beat them, join them. This is exactly what one unnamed Big 4 bank is doing with neolender Wisr (ASX: WZR) as the senior funder of their new $225 million vehicle financing warehouse as more Australians transition away from traditional banking.  The new warehouse will upsize Wisr’s existing $127m facility which will be

    Read More
    Public